The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Vertex had a net margin of 4.73% and a return on equity of 24.92%. On average, equities analysts forecast that Vertex, Inc. will post 0.38 EPS for the current fiscal year. Analyst Ratings Changes ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

When you hear the word calculator, I bet your mind immediately goes to math class and solving problems that can’t be solved efficiently in your head or on paper. While calculators are traditionally ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...